XpanDH Patient Summary
0.1.0 - ci-build
150
XpanDH Patient Summary
0.1.0 - ci-build
150
XpanDH Patient Summary, published by XpanDH Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/xpandh-ps/ and changes regularly. See the Directory of published versions
Contents:
This page provides a list of the FHIR artifacts defined as part of this implementation guide.
Logical models representing the eHN Patient Summary Guidelines
| A - Patient Summary |
A - Patient Summary. eHN guideline model. |
| A.1.1, A.1.2 - Patient or Subject of care |
Patient or Subject of care. Sections A.1.1 and A.1.2 of the eHN guideline. |
| A.2.1.1 - Allergy |
Allergy. Section A.2.1.1 of the eHN guideline. |
| A.2.2.1 - Vaccination/prophylaxis information |
Vaccination/prophylaxis information. Sections A.2.2.1 of the eHN guideline. |
| A.2.2.2 Resolved, closed or inactive problems model to this guide |
Resolved, closed or inactive problems. Sections A.2.2.2 of the eHN guideline. |
| A.2.3.1 Current problems model to this guide |
Current problems. Sections A.2.3.1 of the eHN guideline. |
| A.2.3.2 Medical devices and implants model to this guide |
Medical devices and implants. Sections A.2.3.2 of the eHN guideline. |
| A.2.3.3 Procedures model to this guide |
Procedures. Sections A.2.3.3 of the eHN guideline. |
| A.2.3.3 Functional Status model to this guide |
Functional Status. Sections A.2.3.3 of the eHN guideline. |
| A.2.4.1 Current and relevant past medicines |
Relevant prescribed medicines whose period of time indicated for the treatment has not yet expired whether it has been dispensed or not, or medicines that influence current health status or are relevant to a clinical decision. Section A2.4.1 of the eHN guideline. |
| A.2.6 Pregnancy history model to this guide |
Pregnancy history. Sections A.2.6 of the eHN guideline. |
| A.2.8 Results model to this guide |
Results. Sections A.2.8 of the eHN guideline. |
Concept Maps describing how the eHN Laboratory Guidelines are supposed to be implemented by using this guide
| A - Patient Summary model to this guide |
It shows how the Patient Summary data set defined by the EU eHN guidelines is mapped into this guide. The proposed mapping shows how to represent 'addiitonalInfo' in the casae of a condition, equivalent solution can be applied for other kind of information (e.g. Medications) |
| A.1.1, A.1.2 - Subject of care model to this guide |
It shows how the Subject data set defined by the EU eHN guidelines is mapped into this guide. The group 2 map shows how to map into the Condition reosurce a problem-specific contact. For other kinds of contacts (e.g. contact for a specific procedure) a simlar apporach can be followed. |
| A.2.1.1 - Allergy model to this guide |
It shows how the A.2.1.1 Allergy data set defined by the EU eHN guidelines is mapped into this guide. |
| A.2.2.1 - Vaccination/prophylaxis information model to this guide |
It shows how the A.2.2.1 - Vaccination/prophylaxis information data set defined by the EU eHN guidelines is mapped into this guide. |
| A.2.3.1 Current problems model to this guide |
It shows how the A.2.3.1 Current problems data set defined by the EU eHN guidelines is mapped into this guide. |
| A.2.3.2 Medical devices and implants model to this guide |
It shows how the A.2.3.2 Medical devices and implants data set defined by the EU eHN guidelines is mapped into this guide. |
| A.2.3.3 Functional Status model to this guide |
It shows how the A.2.3.3 Functional Status data set defined by the EU eHN guidelines is mapped into this guide. |
| A.2.3.3 Procedures model to this guide |
It shows how the A.2.3.3 Procedures data set defined by the EU eHN guidelines is mapped into this guide. |
| A.2.4.1 Current and relevant past medicines model to this guide |
It shows how the A.2.4.1 Current and relevant past medicines data set defined by the EU eHN guidelines is mapped into this guide. |
| A.2.6 Pregnancy history model to this guide |
It shows how the A.2.6 Pregnancy history data set defined by the EU eHN guidelines is mapped into this guide. |
| A.2.8 - Results model to this guide |
It shows how the A.2.8 - Results data set defined by the EU eHN guidelines is mapped into this guide. |
These define constraints on FHIR resources for systems conforming to this implementation guide.
| Allergy Intolerance (EU PS) |
This profile constrains the AllergyIntolerance resource for the purpose of the European patient summary. |
| Bundle (EU PS) |
Clinical document used to represent a Patient Summary for the scope of the XpanDH project. |
| CareTeam |
This profile constrains the CareTeam resource for the purpose of the XpanDH project. |
| CareTeam (EU PS) |
This profile constrains the CareTeam resource for the purpose of the European patient summary. |
| Composition (EU PS) |
Clinical document used to represent a Patient Summary for the scope of this project. |
| Condition (EU PS) |
This profile constrains the Condition resource for the purpose of the European patient summary. |
| Device (EU PS) |
This profile constrains the Device resource for the purpose of the European patient summary. |
| Device Use Statement (EU PS) |
This profile constrains the DeviceUseStatement resource for the purpose of the European patient summary. |
| Flag (EU PS) |
This profile constrains the Flag resource to represent alerts or warnings in FHIR for the purpose of this project. |
| Immunization (EU PS) |
This profile constrains the Immunization resource for the purpose of the European patient summary. |
| ImmunizationRecommendation (EU PS) |
This profile defines how to represent Immunization Recommandations for the purpose of the European patient summary. |
| Location (EU PS) |
This profile defines how to represent Location in FHIR for the purpose of the European patient summary. |
| Medication (EU PS) |
This profile constrains the Medication resource for the purpose of the European patient summary. |
| Medication Statement (EU PS) |
This profile constrains the MedicationStatement resource for the purpose of the European patient summary. |
| Observation Results (EU PS) |
This profile constrains the Observation resource to represent various types of results and associated observations in a patient summary. This is the base profile from which the other results profiles are derived. |
| Observation Results: laboratory (EU PS) |
This profile constrains the Observation resource to represent results produced by laboratory studies for the XpanDH project. |
| Observation Results: pathology (EU PS) |
This profile constrains the Observation resource to represent results produced by pathology studies for the XpanDH project. |
| Observation Results: radiology (EU PS) |
This profile constrains the Observation resource to represent results produced by pathology studies for the XpanDH project. |
| Observation Social History (EU PS) |
This profile constrains the Observation resource to represent various types of social history observations in a patient summary. |
| Observation: Blood Group |
This profile constrains the Observation resource to represent various types of results and associated observations in a patient summary. This is the base profile from which the other results profiles are derived. |
| Organization: Care provisioning |
This profile constrains the Organization IPS profile to represent care provisioning organanizations (as RD centers) for the purpose of the XpanDH project. |
| Patient (EU PS) |
This profile defines how to represent Patient in FHIR for the purpose of this guide |
| Practitioner (EU PS) |
This profile defines how to represent Practitioners in FHIR for the purpose of the XpanDH project. |
| PractitionerRole (EU PS) |
This profile defines how to represent Practitioners (with thier roles) in FHIR for the purpose of the XpanDH project. |
| Procedure (EU PS) |
This profile constrains the Procedure resource for the purpose of the European patient summary. |
These define constraints on FHIR data types for systems conforming to this implementation guide.
| Condition Status Reason |
This extension describe the reasons for the condition status, e.g. how this condition has been resolved |
| Immunization AdministeredProduct |
This extension references the Medication administered during the vaccination. It simulates the beahviour of the reference part of the administeredProduct R5 element |
| Supporting Information |
This extension refers other resources from the patient record that may be relevant to the event. The information from these resources was either used to create the instance or is provided to help with its interpretation. This extension should not be used if more specific inline elements or extensions are available. |
These define sets of codes used by systems conforming to this implementation guide.
| Absent or Unknown Allergies |
Absent or Unknown Allergies |
| Absent or Unknown Device |
Absent or Unknown Device |
| Absent or Unknown Medication |
Absent or Unknown Medication |
| Absent or Unknown Problem |
Absent or Unknown Problem |
| Absent or Unknown Procedure |
Absent or Unknown Procedure |
| Active Ingredient |
Active Ingredient |
| Adverse Event Type |
Adverse Event Type |
| Allergen No Drug |
The value set is used to code the patient's kind of adverse reactions against substance, food or drugs |
| Allergens |
Allergens |
| Allergens or no known or unknown conditions |
Allergens or no known or unknown conditions |
| Allergy Certainty |
Value Set is used to support or decline the clinical status of the allergy or intolerance |
| Allergy Status |
The value set is used to code the Allergy or Intolerance Clinical Status |
| Blood Group |
The Value Set is used to code the value of patient's blood group + Rh |
| Blood Pressure |
The Value Set is used for the observations of Blood Pressure recorded in the section for Vital Signs Observations in the Patient Summary. It codes what type of pressure (diastolic, systolic) is measured. |
| Body Site |
The Value Set is used for the details about the anatomical location of a specimen in the Laboratory Result Report or the target body location of a procedure in the Patient Summary |
| Certainty |
Value Set is used to support or decline the clinical status of the condition or diagnosis |
| Conditions |
Conditions |
| Confidentiality |
The Value Set is used for encoding the confidentiality level of the entire CDA. This Value Set encodes the level of access with regards to the content of the Value Set ? for example N concerns all the medical team, R is restricted for specialist that take care of the patient in certain circumstances, and VIP would be for the persons that need the Privacy Officer present or other special consideration (for example a celebrity hospitalized who needs their records protected) |
| Country |
The Value Set is used to identify the nationality of all persons and organizations. |
| Criticality |
Value set is used to estimate of the potential clinical harm, or seriousness, of a reaction to an identified substance |
| Current Pregnancy Status |
Value set is used to provide the woman's current state at the date the observation was made |
| Document Code |
Defines to which category the document belongs to : summary, prescription, or dispensation. |
| Dose Form |
Dose Form |
| Healthcare Professional Role |
Healthcare Professional Role |
| Hospital Discharge Report Type |
Hospital Discharge Report Type |
| Illness and Disorder (PARTIAL) |
The complete content of ICD-10, excluding Chapter XX |
| Medical Device |
Medical Device |
| Problems |
The Value Set is used as an optional description of a problem in the patient Summary. It gives an information on the circumstances under which the problem was defined/discovered. |
| Problems (including unknown conditions) |
Problems (including unknown conditions) |
| Procedure |
Procedure |
| Rare Disease (PARTIAL) |
The Value Set is used to describe the problems and medication reasons. |
| Reaction Allergy |
Reaction Allergy |
| Route of Administration |
Route of Administration |
| Severity |
The Value Set is used for all Problems and Allergies in the Patient Summary to indicate the severity of the problem (or Allergy) |
| Substance (PARTIAL) |
The Value Set is used to code the substances of medicine. |
| Vaccine |
The Value Set is used to identify the patient's vaccinations in the Patient Summary |
| eHDSI Social History |
The Value Set is used to code the different elements of the patient's social history. |
These define transformations to convert between codes by systems conforming with this implementation guide.
| eHN ClosedProblem to this guide Map |
eHN ClosedProblem Model to this guide Map |
IG © 2023+ XpanDH Project. Package hl7.eu.fhir.xpandh.ps#0.1.0 based on FHIR 4.0.1. Generated 2024-12-12
